Research output per year
Research output per year
Personal profile
Research interests
My primary clinical research focus is the implementation of novel analytical methodologies to improve treatment decision-making in patients with cancer.
Clinical interests
Immunotherapy clinical trials, primary brain tumors and brain metastases, melanoma, merkel cell carcinoma.
Available to Mentor:
- PhD/MSTP Students
Fingerprint
Dive into the research topics where Tanner Johanns is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Huang, J., Campian, J. L., DeWees, T. A., Skrott, Z., Mistrik, M., Johanns, T. M., Ansstas, G., Butt, O., Leuthardt, E., Dunn, G. P., Zipfel, G. J., Osbun, J. W., Abraham, C., Badiyan, S., Schwetye, K., Cairncross, J. G., Rubin, J. B., Kim, A. H. & Chheda, M. G., Nov 1 2024, In: International Journal of Radiation Oncology Biology Physics. 120, 3, p. 738-749 12 p.Research output: Contribution to journal › Article › peer-review
-
Case report: Increased efficacy of cetuximab after pembrolizumab failure in cutaneous squamous cell carcinoma
Morecroft, R., Phillipps, J., Zhou, A., Butt, O., Khaddour, K., Johanns, T. & Ansstas, G., 2024, In: Frontiers in Oncology. 14, 1385094.Research output: Contribution to journal › Article › peer-review
Open Access -
Glioblastoma-Infiltrating CD8+ T Cells Are Predominantly a Clonally Expanded GZMK+ Effector Population
Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., Leuthardt, E. C., Kim, A. H., Dowling, J. L., Chicoine, M. R., Jones, P. S., Choi, B. D., Cahill, D. P., Carter, B. S., Petti, A. A. & Johanns, T. M. & 1 others, , Jun 1 2024, In: Cancer discovery. 14, 6, p. 1106-1131 26 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
Johanns, T. M., Garfinkle, E. A. R., Miller, K. E., Livingstone, A. J., Roberts, K. F., Venkata, L. P. R., Dowling, J. L., Chicoine, M. R., Dacey, R. G., Zipfel, G. J., Kim, A. H., Mardis, E. R. & Dunn, G. P., Jul 1 2024, In: Clinical Cancer Research. 30, 13, p. 2729-2742 14 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
A pilot phase Ib study to evaluate tadalafil to overcome immunosuppression during chemoradiotherapy for IDH-wild-Type glioblastoma
Ghosh, S., Johanns, T. M., Chheda, M. G., Liu, E., Butt, O., Abraham, C., Badiyan, S., Huang, Y., Denardo, D., Kim, A. H., Hallahan, D., Thotala, D. & Huang, J., Jan 1 2023, In: Neuro-Oncology Advances. 5, 1, vdad088.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations